RxSight, Inc. 8-K

What Happened

• RxSight, Inc. announced preliminary, unaudited financial and operational results for the second quarter of 2026 in a press release issued July 6, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8‑K (Item 2.02). The Form 8‑K was signed by CFO Mark Wilterding.

Key Details

• Filing date: July 6, 2026 (Form 8‑K filed July 6, 2026).
• Reported Item: 2.02 — Results of Operations and Financial Condition (preliminary, unaudited Q2 results).
• Exhibit: Press release furnished as Exhibit 99.1.
• Signed by: Mark Wilterding, Chief Financial Officer.

Why It Matters

• This filing gives investors an early, high-level view of RxSight’s quarterly performance (earnings/revenue trends) before full audited results are posted.
• Because the figures are preliminary and unaudited, they can be revised in later filings (e.g., Form 10‑Q or subsequent press releases). Investors should look for the company’s detailed quarterly report and any accompanying commentary or conference call for complete, audited figures and context.